Publication
Sulfated small molecules targeting EBV in Burkitt lymphoma: from in silico screening to the evidence of in vitro effect on viral episomal DNA
dc.contributor.author | Lima, Raquel T. | |
dc.contributor.author | Seca, Hugo | |
dc.contributor.author | Palmeira, Andreia | |
dc.contributor.author | Fernandes, Miguel X. | |
dc.contributor.author | Castro, Felipe | |
dc.contributor.author | Correia-da-Silva, Marta | |
dc.contributor.author | Nascimento, Maria S. J. | |
dc.contributor.author | Sousa, Emília | |
dc.contributor.author | Pinto, Madalena | |
dc.contributor.author | Vasconcelos, M. Helena | |
dc.date.accessioned | 2023-02-09T16:00:00Z | |
dc.date.available | 2023-02-09T16:00:00Z | |
dc.date.issued | 2013 | |
dc.description.abstract | Epstein–Barr virus (EBV) infects more than 90% of the world population. Following primary infection, Epstein– Barr virus persists in an asymptomatic latent state. Occasionally, it may switch to lytic infection. Latent EBV infection has been associated with several diseases, such as Burkitt lymphoma (BL). To date, there are no available drugs to target latent EBV, and the existing broad-spec trum antiviral drugs are mainly active against lytic viral infection. Thus, using computational molecular docking, a virtual screen of a library of small molecules, including xanthones and flavonoids (described with potential for antiviral activity against EBV), was carried out targeting EBV proteins. The more interesting molecules were selected for further computational analysis, and sub sequently, the compounds were tested in the Raji (BL) cell line, to evaluate their activity against latent EBV. This work identified three novel sulfated small molecules capable of decreasing EBV levels in a BL. Therefore, the in silico screening presents a good approach for the development of new anti-EBV agents. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Lima, R. T., Seca, H., Palmeira, A., Fernandes, M. X., Castro, F., Correia‐da‐Silva, M., ... & Vasconcelos, M. H. (2013). Sulfated small molecules targeting EBV in Burkitt lymphoma: from in silico screening to the evidence of in vitro effect on viral episomal DNA. Chemical Biology & Drug Design, 81(5), 631-644. | pt_PT |
dc.identifier.doi | 10.1111/cbdd.12109 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.13/5023 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Wiley | pt_PT |
dc.relation | Strategic Project - UI 4040 - 2011-2012 | |
dc.relation | STUDY OF VIRAL ANTIAPOPTOTIC PROTEINS AS POSSIBLE MOLECULAR THERAPEUTIC TARGETS | |
dc.relation | SMALL MOLECULES AS APOPTOSIS INDUCERS IN CANCER CELLS: INVESTIGATION OF THE MECHANISM OF ACTION | |
dc.relation | DEVELOPMENT OF POLYSULFATED SMALL-MOLECULES: TOWARDS NEW ORAL ANTITHROMBOTIC AGENTS | |
dc.relation | UNDERSTANDING THE BIOLOGICAL FUNCTION OF MIRNAS IN ACUTE MYELOID LEUKEMIA | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
dc.subject | Antivirals | pt_PT |
dc.subject | Burkitt lymphoma | pt_PT |
dc.subject | Epstein–Barr virus | pt_PT |
dc.subject | Sulfated small molecules | pt_PT |
dc.subject | Virtual screening | pt_PT |
dc.subject | . | pt_PT |
dc.subject | Faculdade de ciências Exatas e da Engenharia | pt_PT |
dc.title | Sulfated small molecules targeting EBV in Burkitt lymphoma: from in silico screening to the evidence of in vitro effect on viral episomal DNA | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.awardTitle | Strategic Project - UI 4040 - 2011-2012 | |
oaire.awardTitle | STUDY OF VIRAL ANTIAPOPTOTIC PROTEINS AS POSSIBLE MOLECULAR THERAPEUTIC TARGETS | |
oaire.awardTitle | SMALL MOLECULES AS APOPTOSIS INDUCERS IN CANCER CELLS: INVESTIGATION OF THE MECHANISM OF ACTION | |
oaire.awardTitle | DEVELOPMENT OF POLYSULFATED SMALL-MOLECULES: TOWARDS NEW ORAL ANTITHROMBOTIC AGENTS | |
oaire.awardTitle | UNDERSTANDING THE BIOLOGICAL FUNCTION OF MIRNAS IN ACUTE MYELOID LEUKEMIA | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/PEst-OE%2FSAU%2FUI4040%2F2011/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/FARH/SFRH%2FBD%2F21759%2F2005/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT//SFRH%2FBPD%2F68787%2F2010/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/FARH/SFRH%2FBPD%2F81878%2F2011/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/FARH/SFRH%2FBD%2F47428%2F2008/PT | |
oaire.citation.endPage | 644 | pt_PT |
oaire.citation.issue | 5 | pt_PT |
oaire.citation.startPage | 631 | pt_PT |
oaire.citation.title | Chemical Biology & Drug Design | pt_PT |
oaire.citation.volume | 81 | pt_PT |
oaire.fundingStream | 6817 - DCRRNI ID | |
oaire.fundingStream | FARH | |
oaire.fundingStream | FARH | |
oaire.fundingStream | FARH | |
person.familyName | Fernandes | |
person.givenName | Miguel Xavier | |
person.identifier.ciencia-id | ED1D-3C7A-467C | |
person.identifier.orcid | 0000-0002-1840-616X | |
person.identifier.rid | A-4373-2013 | |
person.identifier.scopus-author-id | 35466972500 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 8dab9a0d-f44a-4d2d-b9b1-7b3145162ca3 | |
relation.isAuthorOfPublication.latestForDiscovery | 8dab9a0d-f44a-4d2d-b9b1-7b3145162ca3 | |
relation.isProjectOfPublication | 85f8b1e6-0236-47a6-b77b-6d8826f36004 | |
relation.isProjectOfPublication | f8be6205-9d21-4ba0-9528-10d4aa535c57 | |
relation.isProjectOfPublication | 44e35e5b-8d34-4f7e-bc27-e9fab086365d | |
relation.isProjectOfPublication | dca48bbf-45ba-43ae-8b75-d5ae99a34da5 | |
relation.isProjectOfPublication | 9247624e-8b1f-4ee5-94d4-39ba3390a74a | |
relation.isProjectOfPublication.latestForDiscovery | 44e35e5b-8d34-4f7e-bc27-e9fab086365d |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Sulfated small molecules targeting EBV in Burkitt lymphoma.pdf
- Size:
- 1.34 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: